Call Us: +44 (0) 1752 753723[email protected]
Alzheimer's disease - cord blood treatment

Longeveron Achieves Milestone in Groundbreaking Stem Cell Trial for Alzheimer’s Disease

Longeveron, a leading stem cell research company focused on biological solutions for age-associated diseases, announced today the successful completion of enrollment in the first phase of its clinical research trial of Longeveron allogeneic human mesenchymal stem cells (LMSCsĀ®) to treat Alzheimer’s disease. The fifth and final patient needed for...